Mumbai, India, February 2, 2021: Lupin Limited (Lupin), the global pharmaceutical company, announced the appointment of Mr. Mark D. McDade as an Independent Director effective January 28, 2021.
Mr. McDade is the co-Founder and Partner at Qiming Venture Partners, USA where he led several high-value investments in biotherapeutics, including cell and gene therapy and digital health. With a career spanning over 37 years, he has led and transformed global companies as well as founded and advanced Biotech companies.
Commenting on the appointment, Manju D. Gupta, Chairman, Lupin said, “We are delighted to welcome Mr. Mark D. McDade on Lupin’s board. We are confident that his diverse experience across large, mid and development-stage companies across Specialty & Biologics, will help advance our growth journey.”
Mr. McDade holds a B.A. in History from Dartmouth College and MBA from Harvard Business School.
Are you an aspiring enthusiast willing to develop a career in the medical sales field? The dynamic profile of a medical representative, their exponent...
A healthy gut indicates a healthy you! Isn't that true? In easy words, gut health refers to the balance of microorganisms present in your digestive sy...
Is the scorching sun heat taking a toll on your skin health? The summers trigger all skin types due to excessive humidity and heat around. Dermatologi...
